We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

132 hedge funds and large institutions have $484M invested in Albany Molecular Research Inc in 2014 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 50 increasing their positions, 39 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $3.57M | Put options by funds: $1.19M

28% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 39

8% less funds holding

Funds holding: 143 → 132 (-11)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

28% less capital invested

Capital invested by funds: $669M → $484M (-$185M)

33% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 30

Holders
132
Holders Change
-11
Holders Change %
-7.69%
% of All Funds
3.52%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
20
Increased
50
Reduced
39
Closed
30
Calls
$3.57M
Puts
$1.19M
Net Calls
+$2.38M
Net Calls Change
+$1.48M

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$36.7M
2
VNIM
Vaughan Nelson Investment Management
Texas
+$24.5M
3
PIP
Permian Investment Partners
Texas
+$16.3M
4
IGM
Incline Global Management
New York
+$8.53M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.13M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$19.3M
2
BM
Bridger Management
New York
-$18M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$13.8M
4
Millennium Management
Millennium Management
New York
-$12.9M
5
CPIM
Columbia Partners Investment Management
Virginia
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$3.38M -$611K -33,277 -14%
Deutsche Bank
27
Deutsche Bank
Germany
$3.28M +$1.97M +107,552 +115%
Principal Financial Group
28
Principal Financial Group
Iowa
$2.35M +$37.3K +2,035 +1%
Public Employees Retirement Association of Colorado
29
Public Employees Retirement Association of Colorado
Colorado
$2.17M +$1.46M +79,286 +147%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$2.16M +$308K +16,758 +14%
Natixis Advisors
31
Natixis Advisors
Massachusetts
$2.13M +$2.4M +130,640 New
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$2.12M -$428K -23,325 -15%
Renaissance Technologies
33
Renaissance Technologies
New York
$2.05M -$1.53M -83,100 -40%
FM
34
Forward Management
California
$1.92M +$2.37M +129,400 New
Ameriprise
35
Ameriprise
Minnesota
$1.71M +$28.1K +1,529 +1%
AA
36
Ancora Advisors
Ohio
$1.68M +$45.9K +2,500 +2%
TCIM
37
TIAA CREF Investment Management
New York
$1.66M -$55.7K -3,036 -3%
AI
38
Analytic Investors
California
$1.66M -$49.3K -2,686 -3%
CSC
39
Cove Street Capital
California
$1.63M +$1.84M +100,000 New
First Trust Advisors
40
First Trust Advisors
Illinois
$1.56M -$130K -7,062 -7%
GC
41
Guggenheim Capital
Illinois
$1.54M +$45.5K +2,479 +3%
FSA
42
Franklin Street Advisors
North Carolina
$1.51M +$894K +48,725 +111%
Bessemer Group
43
Bessemer Group
New Jersey
$1.48M – – –
BIM
44
BlackRock Investment Management
Delaware
$1.47M -$16.8K -916 -1%
DCM
45
Decade Capital Management
New York
$1.3M -$5.87M -320,000 -80%
PPA
46
Parametric Portfolio Associates
Washington
$1.2M -$996K -54,285 -42%
Invesco
47
Invesco
Georgia
$1.07M -$4.02M -219,027 -77%
HK
48
Horizon Kinetics
New York
$912K – – –
CS
49
Credit Suisse
Switzerland
$904K +$497K +27,091 +95%
GCP
50
GSA Capital Partners
United Kingdom
$903K +$133K +7,271 +15%
1
2
3 4 5

AMRI Hedge Fund Activity: Q4 2014 in Review

132 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2014, worth a combined $484M — down 28% from $669M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of AMRI and 20 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 50 added.

The largest buyer was Visium Asset Management, adding an estimated $36.7M. The largest seller was Morgan Stanley, cutting an estimated $19.3M.

  • 132 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2014, down from 143 in Q3 2014.
  • Funds reported $484M of Albany Molecular Research Inc stock for Q4 2014, down 28% quarter-over-quarter.
  • 20 funds opened new Albany Molecular Research Inc positions in Q4 2014 and 30 closed out, a net change of -10 holders.
  • The largest Albany Molecular Research Inc buyer in Q4 2014 was Visium Asset Management, an estimated $36.7M added.
  • The largest Albany Molecular Research Inc seller in Q4 2014 was Morgan Stanley, an estimated $19.3M sold.

Based on aggregated 13F filings for Q4 2014.